GATC Health transforms the way drugs are created, developed and financed. Verified at 91% specificity and 86% sensitivity, and trusted by the world’s largest insurance marketplace, our Operon™ platform creates innovative therapeutic solutions, extends pipelines, and optimizes assets. Like a FICO® Score for drug discovery and development, our Derisq™ AI Report delivers objective, Operon-powered insights that help biopharma leaders and investors prioritize assets and predict outcomes – all before committing capital or entering the clinic.
“GATC’s AI has enabled this first-of-a-kind combination of financing protected by insurance in case the clinical trial is not successful. The early response from biotech companies and large brokerage firms for this product has exceeded our expectations which represents the pent-up demand for this innovative financing program.”
Ben Canagaretna
Global Managing Director of Acrisure Re Corporate Advisory & Solutions
We understand who we serve. Our partners are pioneers who see a problem and try to find a solution. And so do we. We step up to the challenge with discipline and imagination.
Break the cycle of risk, cost and delay. Bring scientific integrity and financial confidence to every decision. GATC Health’s predictive analytics aren’t just trusted by scientists. They’re relied upon by some of the largest institutions in the world. Whether you’re an investor, insurer or developer, GATC Health helps you make smarter, lower-risk choices.
